JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMeester, T. R.
Right arrow Articles by Johansson, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMeester, T. R.
Right arrow Articles by Johansson, K. E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 42-54, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Selective therapeutic approach to cancer of the lower esophagus and cardia

TR DeMeester, G Zaninotto and KE Johansson
Department of Surgery, School of Medicine, Creighton University, Omaha, Neb. 68131.

The role of curative en bloc resection for carcinoma of the lower esophagus and cardia is still controversial. The experience with a selective approach in 52 patients with cancer in this location is reviewed. Thirty-two of the cancers were squamous cell, 13 adenocarcinoma, and seven adenocarcinoma associated with Barrett's esophagus. In 19, the tumor was not resectable and all of these patients died within a year. In 19 patients, a palliative resection could be done. Actuarial survival was 31% at 1 year. Only one patient was alive after 5 years. Initially, 16 patients with noncircumferential lesions on endoscopy and/or no evidence of spread to mediastinal lymph nodes on computed tomographic scan were considered to have potentially curable lesions. All were less than 75 years old and had a forced expiratory volume in 1 second greater than 1.5 L and a resting ejection fraction greater than 40%. A curative resection consisting of an en bloc thoracic esophagectomy, mediastinal lymphadenectomy, and an 80% gastrectomy with abdominal lymphadenectomy was performed in 14. The left colon was used to reestablish the gastrointestinal continuity. Two patients had more extensive disease discovered at operation, and the curative en bloc resection was abandoned. Absence of full wall penetration or involvement of four or fewer regional nodes, or both, was correctly predicted by preoperative and intraoperative staging in 86% of the patients. Operative mortality of a curative en bloc resection was 7% (1/14), and the actuarial survival rates were 76%, 66%, and 53% at 1, 2, and 5 years. Inferences are made from these results on tumor characteristics associated with survival, the extent of resection necessary for cure, the difficulty of accomplishing a curative en bloc resection by the transhiatal approach, the contraindication to curative en bloc resection, and the need for a surveillance program for patients with Barrett's esophagus.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. A. Waterman, J. A. Hagen, J. H. Peters, S. R. DeMeester, C. R. Taylor, and T. R. DeMeester
The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma
Ann. Thorac. Surg., October 1, 2004; 78(4): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews
Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches
Oncologist, April 1, 2004; 9(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A M. Fendrick, and N. Vakil
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis
Ann Intern Med, February 4, 2003; 138(3): 176 - 186.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. Shaheen and D. F. Ransohoff
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review
JAMA, April 17, 2002; 287(15): 1972 - 1981.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. H. Kim, K. S. Lee, Y. M. Shim, K. Kim, P. S. Yang, and T. S. Kim
Esophageal Resection: Indications, Techniques, and Radiologic Assessment
RadioGraphics, September 1, 2001; 21(5): 1119 - 1137.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. H. Peters, G. W. B. Clark, A. P. Ireland, P. Chandrasoma, T. C. Smyrk, and T. R. DeMeester
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 813 - 822.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. W. B. Clark, J. H. Peters, A. P. Ireland, A. Ehsan, J. A. Hagen, M. T. Kiyabu, C. G. Bremner, and T. R. DeMeester
Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma
Ann. Thorac. Surg., September 1, 1994; 58(3): 646 - 654.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. B. Skinner
Technical and scientific advances in general thoracic surgery
Ann. Thorac. Surg., January 1, 1990; 49(1): 14 - 25.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.